ALNYLAM PHARMACEUTICALS INC

CUSIP: 02043QAB3 Class: NOTE 1.000% 9/1

CITADEL ADVISORS LLC's Holding History (CIK: 0001423053)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 5,000,000 Value ($000) $6,506 Avg Close — Range —
Q1 2025
Shares 8,000,000 Value ($000) $9,239 Avg Close — Range —
Q2 2024
Shares 27,710,000 Value ($000) $29,866 Avg Close — Range —
Q1 2024
Shares 34,285,000 Value ($000) $32,259 Avg Close — Range —
Q4 2023
Shares 12,422,000 Value ($000) $12,278 Avg Close — Range —
Q3 2023
Shares 44,630,000 Value ($000) $41,369 Avg Close — Range —